ID

20908

Beskrivning

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT00412529

Länk

https://clinicaltrials.gov/show/NCT00412529

Nyckelord

  1. 2017-03-27 2017-03-27 -
Uppladdad den

27 mars 2017

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Hepatitis B NCT00412529

Eligibility Hepatitis B NCT00412529

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, 18-70 years of age with documented compensated hepatitis b "e" antigen (hbeag)-positive chronic hepatitis b
Beskrivning

Age | Chronic Hepatitis B HBeAg positive Compensated

Datatyp

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0524909
UMLS CUI [2,2]
C0392390
UMLS CUI [2,3]
C0205432
able to comply with study regimen and provide written informed consent
Beskrivning

Protocol Compliance | Informed Consent

Datatyp

boolean

Alias
UMLS CUI [1]
C0525058
UMLS CUI [2]
C0021430
Exclusion Criteria
Beskrivning

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breastfeeding
Beskrivning

Pregnancy | Breast Feeding

Datatyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
unwilling to use double barrier method of contraception
Beskrivning

Barrier Contraception Double Unwilling

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0004764
UMLS CUI [1,2]
C0205173
UMLS CUI [1,3]
C0558080
co-infected with hepatitis c virus (hcv), hepatitis d virus (hdv) or human immunodeficiency virus (hiv)
Beskrivning

HCV coinfection | HDV Coinfection | HIV coinfection

Datatyp

boolean

Alias
UMLS CUI [1]
C1698259
UMLS CUI [2,1]
C0011220
UMLS CUI [2,2]
C0275524
UMLS CUI [3]
C4062778
received hepatitis b therapy in the past
Beskrivning

Therapeutic procedure Hepatitis B

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0019163
use of immunomodulatory therapy in past 12 months
Beskrivning

Immunomodulators

Datatyp

boolean

Alias
UMLS CUI [1]
C1527392
history of or symptoms of hepatic decompensation or pancreatitis
Beskrivning

Hepatic decompensation Symptoms | Pancreatitis Symptoms

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1394798
UMLS CUI [1,2]
C1457887
UMLS CUI [2,1]
C0030305
UMLS CUI [2,2]
C1457887
frequent or prolonged use of potentially hepatotoxic or nephrotoxic drugs
Beskrivning

Hepatotoxicity Pharmaceutical Preparations Frequent | Hepatotoxicity Pharmaceutical Preparations Prolonged | Pharmaceutical Preparations Nephrotoxic Frequent | Pharmaceutical Preparations Nephrotoxic Prolonged

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0235378
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0332183
UMLS CUI [2,1]
C0235378
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0439590
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C1514118
UMLS CUI [3,3]
C0332183
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C1514118
UMLS CUI [4,3]
C0439590
concurrent medication likely to preclude compliance with schedule of evaluations
Beskrivning

Pharmaceutical Preparation Excludes Protocol Compliance

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0525058
use of other investigational drugs within 30 days of enrollment
Beskrivning

Investigational New Drugs

Datatyp

boolean

Alias
UMLS CUI [1]
C0013230
abnormal laboratory values during screening
Beskrivning

Laboratory test result abnormal

Datatyp

boolean

Alias
UMLS CUI [1]
C0438215
other protocol-defined inclusion/exclusion criteria may apply
Beskrivning

Clinical Trial Eligibility Criteria Study Protocol

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563

Similar models

Eligibility Hepatitis B NCT00412529

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Age | Chronic Hepatitis B HBeAg positive Compensated
Item
male or female, 18-70 years of age with documented compensated hepatitis b "e" antigen (hbeag)-positive chronic hepatitis b
boolean
C0001779 (UMLS CUI [1])
C0524909 (UMLS CUI [2,1])
C0392390 (UMLS CUI [2,2])
C0205432 (UMLS CUI [2,3])
Protocol Compliance | Informed Consent
Item
able to comply with study regimen and provide written informed consent
boolean
C0525058 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Barrier Contraception Double Unwilling
Item
unwilling to use double barrier method of contraception
boolean
C0004764 (UMLS CUI [1,1])
C0205173 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
HCV coinfection | HDV Coinfection | HIV coinfection
Item
co-infected with hepatitis c virus (hcv), hepatitis d virus (hdv) or human immunodeficiency virus (hiv)
boolean
C1698259 (UMLS CUI [1])
C0011220 (UMLS CUI [2,1])
C0275524 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
Therapeutic procedure Hepatitis B
Item
received hepatitis b therapy in the past
boolean
C0087111 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
Immunomodulators
Item
use of immunomodulatory therapy in past 12 months
boolean
C1527392 (UMLS CUI [1])
Hepatic decompensation Symptoms | Pancreatitis Symptoms
Item
history of or symptoms of hepatic decompensation or pancreatitis
boolean
C1394798 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0030305 (UMLS CUI [2,1])
C1457887 (UMLS CUI [2,2])
Hepatotoxicity Pharmaceutical Preparations Frequent | Hepatotoxicity Pharmaceutical Preparations Prolonged | Pharmaceutical Preparations Nephrotoxic Frequent | Pharmaceutical Preparations Nephrotoxic Prolonged
Item
frequent or prolonged use of potentially hepatotoxic or nephrotoxic drugs
boolean
C0235378 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0332183 (UMLS CUI [1,3])
C0235378 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439590 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C1514118 (UMLS CUI [3,2])
C0332183 (UMLS CUI [3,3])
C0013227 (UMLS CUI [4,1])
C1514118 (UMLS CUI [4,2])
C0439590 (UMLS CUI [4,3])
Pharmaceutical Preparation Excludes Protocol Compliance
Item
concurrent medication likely to preclude compliance with schedule of evaluations
boolean
C0013227 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Investigational New Drugs
Item
use of other investigational drugs within 30 days of enrollment
boolean
C0013230 (UMLS CUI [1])
Laboratory test result abnormal
Item
abnormal laboratory values during screening
boolean
C0438215 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial